Renin-ANG System in Morphogenesis of Renal Medulla
肾素-ANG 系统在肾髓质形态发生中的作用
基本信息
- 批准号:7987451
- 负责人:
- 金额:$ 7.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-01 至 2010-11-30
- 项目状态:已结题
- 来源:
- 关键词:AGTR2 geneAgonistAngiotensin IIAngiotensinogenAngiotensinsApoptosisBMP4Cell ProliferationCellsChildhoodComputer Systems DevelopmentCongenital AbnormalityDaughterDefectDevelopmentDuct (organ) structureEmbryoEpitheliumFactor AnalysisFluorescence MicroscopyGene ExpressionGenesGeneticGreen Fluorescent ProteinsGrowthGrowth and Development functionHydronephrosisIn Situ HybridizationInterventionKidneyKidney FailureKidney PapillaKnockout MiceKnowledgeLabelMediatingMesenchymalMesenchymeMetanephric DiverticulumMetanephric structureMolecularMorphogenesisMusMutant Strains MiceMutationPapillaryPathogenesisPhenotypePreventionPreventiveProcessProductionRenin-Angiotensin SystemResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRoleStagingTestingTherapeutic InterventionTransgenic MiceTransgenic OrganismsUrinary tractdesignin vivokidney medullakidney vascular structuremutantnephrogenesisnull mutationparacrineprogramspromoterreceptorspatiotemporaltime usetongue papillaurinary
项目摘要
DESCRIPTION (provided by applicant): Congenital abnormalities of the kidney and urinary tract (CAKUT) are the major cause of renal failure in childhood. In order to develop more effective preventive and therapeutic interventions, it is important to better understand the molecular pathogenesis of CAKUT. Branching morphogenesis in the developing kidney involves growth and branching of the ureteric bud (UB) and its daughter collecting ducts. Even subtle defects in the efficiency and/or accuracy of this process have profound effects on the ultimate development of the kidney. The renin-angiotensin system (RAS) is required for the proper development of the renal medulla and papilla, since mutations in the genes encoding components of the RAS in mice cause renal papillary hypoplasia, hydronephrosis, and urinary concentrating defect. In addition, the UB branches and surrounding mesenchymal stroma express angiotensinogen (ACT) and angiotensin (ANG) IIAT1/AT2 receptors. These findings imply that UB-derived epithelia are targets for ANG II actions during metanephric kidney development. In this proposal, we will test the overall hypothesis that ANG II regulates both early and late steps of renal collecting system development. In Aim 1, we will utilize AGT-deficient mice expressing green fluorescent protein in the UB to test the hypothesis that endogenous ANG II is required for UB branching morphogenesis during early metanephric development. Aim 2 will test the hypothesis that ANG II stimulates papillogenesis during late metanephric development. Aim 3 will test the hypothesis that transgenic expression of AT1 receptor in the UB of AT1-deficient mice rescues UB growth and branching. Aim 4 will characterize the cross-talk between the RAS and stromal factors important for UB branching morphogenesis and papillary development. The results of the proposed studies should yield new knowledge on the role of ANG II in UB/papillary growth and development. Such information can be utilized for the design of interventional strategies aimed at the prevention and treatment of CAKUT.
描述(由申请人提供):先天性肾脏和尿路异常(ckut)是儿童肾衰竭的主要原因。为了制定更有效的预防和治疗措施,更好地了解CAKUT的分子发病机制至关重要。肾发育中的分支形态发生涉及输尿管芽(UB)及其子集管的生长和分支。即使这个过程中效率和/或准确性上的细微缺陷也会对肾脏的最终发育产生深远的影响。肾素-血管紧张素系统(RAS)对于肾髓质和乳头的正常发育是必需的,因为在小鼠中编码RAS成分的基因突变会导致肾乳头发育不全、肾积水和尿浓缩缺陷。此外,UB分支和周围间质间质表达血管紧张素原(ACT)和血管紧张素(ANG) IIAT1/AT2受体。这些发现表明ub源性上皮是后肾发育过程中ANG II作用的靶点。在本提案中,我们将测试ANG II调节肾脏收集系统发育的早期和后期步骤的总体假设。在Aim 1中,我们将利用在UB中表达绿色荧光蛋白的agt缺陷小鼠来验证在早期后肾发育过程中UB分支形态发生需要内源性ANG II的假设。目的2将检验在后肾发育后期ANG II刺激乳头形成的假设。目的3将验证AT1缺陷小鼠UB中AT1受体的转基因表达是否能挽救UB的生长和分支。目的4将描述RAS和间质因子之间的串扰,这些因子对UB分支形态发生和乳头发育至关重要。拟议研究的结果应该对ANG II在UB/乳头生长发育中的作用有新的认识。这些信息可用于设计旨在预防和治疗CAKUT的干预战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ihor V Yosypiv其他文献
Ihor V Yosypiv的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ihor V Yosypiv', 18)}}的其他基金
TULANE COBRE: TRANSGENIC & GENE-TARGETED ANIMAL CORE
TULANE COBRE:转基因
- 批准号:
8167892 - 财政年份:2010
- 资助金额:
$ 7.33万 - 项目类别:
TULANE COBRE: ANGIOTENSIN IN DISTAL NEPHRON ONTOGENY
TULANE COBRE:远端肾单位个体发育中的血管紧张素
- 批准号:
7610412 - 财政年份:2007
- 资助金额:
$ 7.33万 - 项目类别:
Renin-ANG System in Morphogenesis of Renal Medulla
肾素-ANG 系统在肾髓质形态发生中的作用
- 批准号:
7193315 - 财政年份:2007
- 资助金额:
$ 7.33万 - 项目类别:
Renin-ANG System in Morphogenesis of Renal Medulla
肾素-ANG 系统在肾髓质形态发生中的作用
- 批准号:
8065538 - 财政年份:2007
- 资助金额:
$ 7.33万 - 项目类别:
Renin-ANG System in Morphogenesis of Renal Medulla
肾素-ANG 系统在肾髓质形态发生中的作用
- 批准号:
7616710 - 财政年份:2007
- 资助金额:
$ 7.33万 - 项目类别:
Renin-ANG System in Morphogenesis of Renal Medulla
肾素-ANG 系统在肾髓质形态发生中的作用
- 批准号:
7766734 - 财政年份:2007
- 资助金额:
$ 7.33万 - 项目类别:
Renin-ANG System in Morphogenesis of Renal Medulla
肾素-ANG 系统在肾髓质形态发生中的作用
- 批准号:
7418621 - 财政年份:2007
- 资助金额:
$ 7.33万 - 项目类别:
TULANE COBRE: ANGIOTENSIN IN DISTAL NEPHRON ONTOGENY
TULANE COBRE:远端肾单位个体发育中的血管紧张素
- 批准号:
7381797 - 财政年份:2006
- 资助金额:
$ 7.33万 - 项目类别:
TULANE COBRE: ANGIOTENSIN IN DISTAL NEPHRON ONTOGENY
TULANE COBRE:远端肾单位个体发育中的血管紧张素
- 批准号:
7171017 - 财政年份:2005
- 资助金额:
$ 7.33万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 7.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 7.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 7.33万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 7.33万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 7.33万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 7.33万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 7.33万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 7.33万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 7.33万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 7.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




